Perhaps you don't understand the nature and boom then drop cycles of early stage bios. It is not managements job to monitor daily share price and enter into their own forms of manipulation to satisfy the emotions of traders or shareholders. The fact that shorters trade AVXL has nothing to do with Missling. It is a function of the market and what is allowed by the SEC and oversight agencies.
It is managements job to build the company and advance the science, which is exactly what is being accomplished here. The ensuing growth then becomes reflected in share price. This is how it works.
Pull up 5 year charts of low priced early stage bios and they all show similar cycles. Read the histories on those boards and one will also find judgmental attitude toward even the most successful management. Case in point, Pharmacyclics.
Wish prosperity to all the AVXL longs.
Disclaimer: the above is just one opinion. Others may have differing opinions. Everyone must do their own dd and make their own decisions individually.
News 
Market Data 
Discover 
